Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Quantification of esophageal tumor motion and investigation of different image-guided correction strategies.

Voncken FEM, Nakhaee S, Stam B, Wiersema L, Vollenbrock SE, van Dieren JM, van Leerdam ME, Sonke JJ, Aleman BMP, Remeijer P.

Pract Radiat Oncol. 2019 Nov 28. pii: S1879-8500(19)30361-3. doi: 10.1016/j.prro.2019.11.012. [Epub ahead of print]

PMID:
31786235
2.

EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types.

Rigter LS, Rijkmans EC, Inderson A, van den Ende RPJ, Kerkhof EM, Ketelaars M, van Dieren J, Veenendaal RA, van Triest B, Marijnen CAM, van der Heide UA, van Leerdam ME.

Endosc Int Open. 2019 Nov;7(11):E1357-E1364. doi: 10.1055/a-0958-2148. Epub 2019 Oct 22.

3.

Endoscopic management of Lynch syndrome and of familial risk of colorectal cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

van Leerdam ME, Roos VH, van Hooft JE, Balaguer F, Dekker E, Kaminski MF, Latchford A, Neumann H, Ricciardiello L, Rupińska M, Saurin JC, Tanis PJ, Wagner A, Jover R, Pellisé M.

Endoscopy. 2019 Nov;51(11):1082-1093. doi: 10.1055/a-1016-4977. Epub 2019 Oct 9.

4.

Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis.

Roos VH, Mangas-Sanjuan C, Rodriguez-Girondo M, Medina-Prado L, Steyerberg EW, Bossuyt PMM, Dekker E, Jover R, van Leerdam ME.

Clin Gastroenterol Hepatol. 2019 Dec;17(13):2657-2667.e9. doi: 10.1016/j.cgh.2019.09.007. Epub 2019 Sep 13. Review.

PMID:
31525516
5.

Feasibility of Gold Fiducial Markers as a Surrogate for Gross Tumor Volume Position in Image-Guided Radiation Therapy of Rectal Cancer.

van den Ende RPJ, Kerkhof EM, Rigter LS, van Leerdam ME, Peters FP, van Triest B, Staring M, Marijnen CAM, van der Heide UA.

Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):1151-1159. doi: 10.1016/j.ijrobp.2019.08.052. Epub 2019 Aug 30.

6.

Incidence of Interval Colorectal Cancer After Negative Results From First-Round Fecal Immunochemical Screening Tests, by Cutoff Value and Participant Sex and Age.

Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MCW, Opstal-van Winden AWJ, Ramakers C, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, Nagtegaal ID, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group.

Clin Gastroenterol Hepatol. 2019 Aug 20. pii: S1542-3565(19)30896-1. doi: 10.1016/j.cgh.2019.08.021. [Epub ahead of print]

7.

Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study.

Bleijenberg AGC, IJspeert JEG, Carballal S, Pellise M, Jung G, van Herwaarden YJ, Bisseling TM, Nagtegaal ID, van Leerdam ME, Spaander MCW, van Lelyveld N, Bessa X, Rodríguez-Alcalde D, Bastiaansen BAJ, de Klaver W, Bemelman WA, Bujanda L, Koornstra JJ, Rivero L, Rodríguez-Moranta F, Balaguer F, Dekker E.

Am J Gastroenterol. 2019 Sep;114(9):1512-1519. doi: 10.14309/ajg.0000000000000339.

PMID:
31403493
8.

Endoscopic management of polyposis syndromes: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.

van Leerdam ME, Roos VH, van Hooft JE, Dekker E, Jover R, Kaminski MF, Latchford A, Neumann H, Pellisé M, Saurin JC, Tanis PJ, Wagner A, Balaguer F, Ricciardiello L.

Endoscopy. 2019 Sep;51(9):877-895. doi: 10.1055/a-0965-0605. Epub 2019 Jul 23.

9.

Somatic mosaicism by a de novo MLH1 mutation as a cause of Lynch syndrome.

Geurts-Giele WR, Rosenberg EH, Rens AV, Leerdam MEV, Dinjens WN, Bleeker FE.

Mol Genet Genomic Med. 2019 Jul;7(7):e00699. doi: 10.1002/mgg3.699. Epub 2019 May 18.

10.

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients.

Vleugels JLA, van Neerven SM, van Leerdam ME, Wanders LK, de Wit M, Carvalho B, Delis-van Diemen PM, Kallenberg FGJ, Vermeulen L, Beliën JA, East JE, Meijer GA, Dekker E.

Endosc Int Open. 2019 May;7(5):E701-E707. doi: 10.1055/a-0832-8283. Epub 2019 May 8.

11.

Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study.

Bleijenberg AG, IJspeert JE, van Herwaarden YJ, Carballal S, Pellisé M, Jung G, Bisseling TM, Nagetaal ID, van Leerdam ME, van Lelyveld N, Bessa X, Rodríguez-Moranta F, Bastiaansen B, de Klaver W, Rivero L, Spaander MC, Koornstra JJ, Bujanda L, Balaguer F, Dekker E.

Gut. 2020 Jan;69(1):112-121. doi: 10.1136/gutjnl-2018-318134. Epub 2019 Apr 13.

12.

Nutritional and vitamin status in patients with neuroendocrine neoplasms.

Clement DS, Tesselaar ME, van Leerdam ME, Srirajaskanthan R, Ramage JK.

World J Gastroenterol. 2019 Mar 14;25(10):1171-1184. doi: 10.3748/wjg.v25.i10.1171. Review.

13.

MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.

van den Ende RPJ, Rigter LS, Kerkhof EM, van Persijn van Meerten EL, Rijkmans EC, Lambregts DMJ, van Triest B, van Leerdam ME, Staring M, Marijnen CAM, van der Heide UA.

Radiother Oncol. 2019 Mar;132:93-99. doi: 10.1016/j.radonc.2018.11.016. Epub 2018 Dec 21.

14.

Yield of Surveillance Colonoscopies 1 Year After Curative Surgical Colorectal Cancer Resections.

van Lanschot MCJ, van Leerdam ME, Lansdorp-Vogelaar I, Doets S, Nagtegaal ID, Schreurs HW, van der Hulst RWM, Carvalho B, Dekker E, van Berkel AM.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2285-2293. doi: 10.1016/j.cgh.2019.02.026. Epub 2019 Feb 22.

PMID:
30802606
15.

Quality Monitoring of a FIT-Based Colorectal Cancer Screening Program.

Toes-Zoutendijk E, Bonfrer JMG, Ramakers C, Thelen M, Spaander MCW, Dekker E, van der Meulen MP, Buskermolen M, van Vuuren AJ, Kuipers EJ, van Kemenade FJ, van Velthuysen MF, Thomeer MGJ, van Veldhuizen H, van Ballegooijen M, de Koning HJ, van Leerdam ME, Lansdorp-Vogelaar I.

Clin Chem. 2019 Mar;65(3):419-426. doi: 10.1373/clinchem.2018.294041. Epub 2019 Jan 16.

PMID:
30651228
16.

Overall and disease-specific survival of Hodgkin lymphoma survivors who subsequently developed gastrointestinal cancer.

Rigter LS, Schaapveld M, Janus CPM, Krol ADG, van der Maazen RWM, Roesink J, Zijlstra JM, van Imhoff GW, Poortmans PMP, Beijert M, Lugtenburg PJ, Visser O, Snaebjornsson P, van Eggermond AM, Aleman BMP, van Leeuwen FE, van Leerdam ME.

Cancer Med. 2019 Jan;8(1):190-199. doi: 10.1002/cam4.1922. Epub 2018 Dec 27.

17.

High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.

Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, Meijer GA, de Boer JP, van Leeuwen FE, van Leerdam ME.

Cancer. 2019 Mar 15;125(6):990-999. doi: 10.1002/cncr.31903. Epub 2018 Dec 18.

18.

A squamous cell carcinoma in a young woman with Lynch syndrome.

Adan F, Crijns MB, Dekker E, Bastiaansen BAJ, Lapid O, Snaebjornsson P, Rosenberg EH, van Leerdam ME, Bekkenk MW.

Fam Cancer. 2019 Apr;18(2):193-196. doi: 10.1007/s10689-018-00113-5.

PMID:
30560308
19.

Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program.

Bronzwaer MES, Depla ACTM, van Lelyveld N, Spanier BWM, Oosterhout YH, van Leerdam ME, Spaander MCW, Dekker E; Dutch Colonoscopy Quality Assurance working group.

Gastrointest Endosc. 2019 Jan;89(1):1-13. doi: 10.1016/j.gie.2018.09.011. Epub 2018 Sep 18. Review.

PMID:
30240879
20.

Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids.

Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF, Slagter M, van der Velden DL, Kaing S, Kelderman S, van Rooij N, van Leerdam ME, Depla A, Smit EF, Hartemink KJ, de Groot R, Wolkers MC, Sachs N, Snaebjornsson P, Monkhorst K, Haanen J, Clevers H, Schumacher TN, Voest EE.

Cell. 2018 Sep 6;174(6):1586-1598.e12. doi: 10.1016/j.cell.2018.07.009. Epub 2018 Aug 9.

21.

Rapid on-site evaluation during endoscopic ultrasound-guided fine-needle aspiration of lymph nodes does not increase diagnostic yield: A randomized, multicenter trial.

Kappelle WFW, Van Leerdam ME, Schwartz MP, Bülbül M, Buikhuisen WA, Brink MA, Sie-Go DMDS, Pullens HJM, Nikolakopoulos S, Van Diest PJ, Leenders M, Moons LMG, Bogte A, Siersema PD, Vleggaar FP.

Am J Gastroenterol. 2018 May;113(5):677-685. doi: 10.1038/s41395-018-0025-8. Epub 2018 Apr 23.

PMID:
29681624
22.

Cumulative risk of skin tumours in patients with Lynch syndrome.

Adan F, Crijns MB, Zandstra WSE, Bekkenk MW, Bleeker FE, Dekker E, van Leerdam ME.

Br J Dermatol. 2018 Aug;179(2):522-523. doi: 10.1111/bjd.16552. Epub 2018 May 29. No abstract available.

PMID:
29542113
23.

Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment.

Rigter LS, Snaebjornsson P, Rosenberg EH, Atmodimedjo PN, Aleman BM, Ten Hoeve J, Geurts-Giele WR; PALGA group, van Ravesteyn TW, Hoeksel J, Meijer GA, Te Riele H, van Leeuwen FE, Dinjens WN, van Leerdam ME.

Gut. 2018 Mar;67(3):447-455. doi: 10.1136/gutjnl-2016-312608. Epub 2016 Nov 8.

PMID:
29439113
24.

Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management.

Geukes Foppen MH, Rozeman EA, van Wilpe S, Postma C, Snaebjornsson P, van Thienen JV, van Leerdam ME, van den Heuvel M, Blank CU, van Dieren J, Haanen JBAG.

ESMO Open. 2018 Jan 13;3(1):e000278. doi: 10.1136/esmoopen-2017-000278. eCollection 2018. Review.

25.

Chemoprevention in Patients with Peutz-Jeghers Syndrome: Lessons Learned.

de Brabander J, Eskens FALM, Korsse SE, Dekker E, Dewint P, van Leerdam ME, van Eeden S, Klümpen HJ.

Oncologist. 2018 Apr;23(4):399-e33. doi: 10.1634/theoncologist.2017-0682. Epub 2018 Jan 25.

26.

Endoscopic detection rate of sessile serrated lesions in Lynch syndrome patients is comparable with an age- and gender-matched control population: case-control study with expert pathology review.

Vleugels JLA, Sahin H, Hazewinkel Y, Koens L, van den Berg JG, van Leerdam ME, Dekker E.

Gastrointest Endosc. 2018 May;87(5):1289-1296. doi: 10.1016/j.gie.2017.11.034. Epub 2017 Dec 9.

PMID:
29233671
27.

Stage distribution of screen-detected colorectal cancers in the Netherlands.

Toes-Zoutendijk E, Kooyker AI, Elferink MA, Spaander MCW, Dekker E, Koning HJ, Lemmens VE, van Leerdam ME, Lansdorp-Vogelaar I; LECO working group.

Gut. 2018 Sep;67(9):1745-1746. doi: 10.1136/gutjnl-2017-315111. Epub 2017 Oct 21. No abstract available.

PMID:
29055907
28.
29.

Incidence of small bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy.

Haanstra JF, Al-Toma A, Dekker E, Vanhoutvin SALW, Nagengast FM, Mathus-Vliegen EM, van Leerdam ME, de Vos Tot Nederveen Cappel WH, Veenendaal RA, Cats A, Sanduleanu S, Vasen HFA, Kleibeuker JH, Koornstra JJ.

Endosc Int Open. 2017 Jul;5(7):E622-E626. doi: 10.1055/s-0043-111723. Epub 2017 Jul 6.

30.

Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.

van Eggermond AM, Schaapveld M, Janus CP, de Boer JP, Krol AD, Zijlstra JM, van der Maazen RW, Kremer LC, van Leerdam ME, Louwman MW, Visser O, De Bruin ML, Aleman BM, van Leeuwen FE.

Br J Cancer. 2017 Jul 25;117(3):306-314. doi: 10.1038/bjc.2017.177. Epub 2017 Jun 20.

31.

Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness Analysis.

Meulen MPV, Kapidzic A, Leerdam MEV, van der Steen A, Kuipers EJ, Spaander MCW, de Koning HJ, Hol L, Lansdorp-Vogelaar I.

Cancer Epidemiol Biomarkers Prev. 2017 Aug;26(8):1328-1336. doi: 10.1158/1055-9965.EPI-16-0786. Epub 2017 May 17.

32.

Timing of Systemic Chemotherapy in Patients With Colorectal Peritoneal Carcinomatosis Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

van Eden WJ, Kok NF, Jóźwiak K, Lahaye ML, Beets GL, van Leerdam ME, Boot H, Aalbers AG.

Dis Colon Rectum. 2017 May;60(5):477-487. doi: 10.1097/DCR.0000000000000774.

PMID:
28383447
33.

Gastrointestinal diseases and their oro-dental manifestations: Part 4: Peutz-Jeghers syndrome.

Korsse SE, van Leerdam ME, Dekker E.

Br Dent J. 2017 Feb 10;222(3):214-217. doi: 10.1038/sj.bdj.2017.127.

PMID:
28184053
34.

Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.

Rigter LS, Spaander MC, Moons LM, Bisseling TM, Aleman BM, de Boer JP, Lugtenburg PJ, Janus CP, Petersen EJ, Roesink JM, Raemaekers JM, van der Maazen RW, Cats A, Bleiker EM, Snaebjornsson P, Carvalho B, Lansdorp-Vogelaar I, Jóźwiak K, Te Riele H, Meijer GA, van Leeuwen FE, van Leerdam ME.

BMC Cancer. 2017 Feb 7;17(1):112. doi: 10.1186/s12885-017-3089-8.

35.

Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels.

Toes-Zoutendijk E, van Leerdam ME, Dekker E, van Hees F, Penning C, Nagtegaal I, van der Meulen MP, van Vuuren AJ, Kuipers EJ, Bonfrer JMG, Biermann K, Thomeer MGJ, van Veldhuizen H, Kroep S, van Ballegooijen M, Meijer GA, de Koning HJ, Spaander MCW, Lansdorp-Vogelaar I; Dutch National Colorectal Cancer Screening Working Group.

Gastroenterology. 2017 Mar;152(4):767-775.e2. doi: 10.1053/j.gastro.2016.11.022. Epub 2016 Nov 24.

PMID:
27890769
36.

A case series of intestinal adenomatous polyposis of unidentified etiology; a late effect of irradiation?

Rigter LS, Kallenberg FG, Bastiaansen B, van Os TA, van Leeuwen FE, van Leerdam ME, Dekker E.

BMC Cancer. 2016 Nov 8;16(1):862.

37.

A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer.

Borstlap WA, Tanis PJ, Koedam TW, Marijnen CA, Cunningham C, Dekker E, van Leerdam ME, Meijer G, van Grieken N, Nagtegaal ID, Punt CJ, Dijkgraaf MG, De Wilt JH, Beets G, de Graaf EJ, van Geloven AA, Gerhards MF, van Westreenen HL, van de Ven AW, van Duijvendijk P, de Hingh IH, Leijtens JW, Sietses C, Spillenaar-Bilgen EJ, Vuylsteke RJ, Hoff C, Burger JW, van Grevenstein WM, Pronk A, Bosker RJ, Prins H, Smits AB, Bruin S, Zimmerman DD, Stassen LP, Dunker MS, Westerterp M, Coene PP, Stoot J, Bemelman WA, Tuynman JB.

BMC Cancer. 2016 Jul 21;16:513. doi: 10.1186/s12885-016-2557-x.

38.

Small-bowel Surveillance in Patients With Peutz-Jeghers Syndrome: Comparing Magnetic Resonance Enteroclysis and Double Balloon Enteroscopy.

Goverde A, Korsse SE, Wagner A, van Leerdam ME, Krak NC, Stoker J, van Buuren HR, Hofstra RM, Bruno MJ, Dewint P, Dekker E, Spaander MC.

J Clin Gastroenterol. 2017 Apr;51(4):e27-e33. doi: 10.1097/MCG.0000000000000592.

PMID:
27404294
39.

Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme.

Kallenberg FG, Vleugels JL, de Wijkerslooth TR, Stegeman I, Stoop EM, van Leerdam ME, Kuipers EJ, Bossuyt PM, Dekker E.

Aliment Pharmacol Ther. 2016 Jul;44(1):88-96. doi: 10.1111/apt.13660. Epub 2016 May 12.

40.

CT-Colonography vs. Colonoscopy for Detection of High-Risk Sessile Serrated Polyps.

IJspeert JE, Tutein Nolthenius CJ, Kuipers EJ, van Leerdam ME, Nio CY, Thomeer MG, Biermann K, van de Vijver MJ, Dekker E, Stoker J.

Am J Gastroenterol. 2016 Apr;111(4):516-22. doi: 10.1038/ajg.2016.58. Epub 2016 Mar 29.

PMID:
27021193
41.

Cost-effectiveness of routine screening for Lynch syndrome in colorectal cancer patients up to 70 years of age.

Leenen CH, Goverde A, de Bekker-Grob EW, Wagner A, van Lier MG, Spaander MC, Bruno MJ, Tops CM, van den Ouweland AM, Dubbink HJ, Kuipers EJ, Dinjens WN, van Leerdam ME, Steyerberg EW.

Genet Med. 2016 Oct;18(10):966-73. doi: 10.1038/gim.2015.206. Epub 2016 Mar 3.

PMID:
26938782
42.

Crizotinib-induced fatal fulminant liver failure.

van Geel RM, Hendrikx JJ, Vahl JE, van Leerdam ME, van den Broek D, Huitema AD, Beijnen JH, Schellens JH, Burgers SA.

Lung Cancer. 2016 Mar;93:17-9. doi: 10.1016/j.lungcan.2015.12.010. Epub 2015 Dec 30.

PMID:
26898609
43.

Smoking status informs about the risk of advanced serrated polyps in a screening population.

IJspeert JE, Bossuyt PM, Kuipers EJ, Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E.

Endosc Int Open. 2016 Jan;4(1):E73-8. doi: 10.1055/s-0034-1393361. Epub 2015 Nov 27.

44.

Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.

IJspeert JE, Rana SA, Atkinson NS, van Herwaarden YJ, Bastiaansen BA, van Leerdam ME, Sanduleanu S, Bisseling TM, Spaander MC, Clark SK, Meijer GA, van Lelyveld N, Koornstra JJ, Nagtegaal ID, East JE, Latchford A, Dekker E; Dutch workgroup serrated polyps & polyposis (WASP).

Gut. 2017 Feb;66(2):278-284. doi: 10.1136/gutjnl-2015-310630. Epub 2015 Nov 24.

45.

Genetic testing for Lynch syndrome: family communication and motivation.

Leenen CH, Heijer Md, van der Meer C, Kuipers EJ, van Leerdam ME, Wagner A.

Fam Cancer. 2016 Jan;15(1):63-73. doi: 10.1007/s10689-015-9842-8.

46.

Attendance and diagnostic yield of repeated two-sample faecal immunochemical test screening for colorectal cancer.

Kapidzic A, van Roon AH, van Leerdam ME, van Vuuren AJ, van Ballegooijen M, Lansdorp-Vogelaar I, Spijker W, Izelaar K, Hol L, Kuipers EJ.

Gut. 2017 Jan;66(1):118-123. doi: 10.1136/gutjnl-2014-308957. Epub 2015 Sep 14.

PMID:
26370109
47.

Metachronous colorectal cancer: Is it all about colonoscopy quality?

Dekker E, van Leerdam ME.

Gastrointest Endosc. 2015 Aug;82(2):334-6. doi: 10.1016/j.gie.2015.03.1903. No abstract available.

PMID:
26183494
48.

Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps.

IJspeert JE, Bastiaansen BA, van Leerdam ME, Meijer GA, van Eeden S, Sanduleanu S, Schoon EJ, Bisseling TM, Spaander MC, van Lelyveld N, Bargeman M, Wang J, Dekker E; Dutch Workgroup serrAted polypS & Polyposis (WASP).

Gut. 2016 Jun;65(6):963-70. doi: 10.1136/gutjnl-2014-308411. Epub 2015 Mar 9.

PMID:
25753029
49.

Gender Differences in Fecal Immunochemical Test Performance for Early Detection of Colorectal Neoplasia.

Kapidzic A, van der Meulen MP, Hol L, van Roon AH, Looman CW, Lansdorp-Vogelaar I, van Ballegooijen M, van Vuuren AJ, Reijerink JC, van Leerdam ME, Kuipers EJ.

Clin Gastroenterol Hepatol. 2015 Aug;13(8):1464-71.e4. doi: 10.1016/j.cgh.2015.02.023. Epub 2015 Feb 24.

PMID:
25724706
50.

Polyp morphology: an interobserver evaluation for the Paris classification among international experts.

van Doorn SC, Hazewinkel Y, East JE, van Leerdam ME, Rastogi A, Pellisé M, Sanduleanu-Dascalescu S, Bastiaansen BA, Fockens P, Dekker E.

Am J Gastroenterol. 2015 Jan;110(1):180-7. doi: 10.1038/ajg.2014.326. Epub 2014 Oct 21.

PMID:
25331346

Supplemental Content

Loading ...
Support Center